GEMP - Gemphire Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Gemphire Therapeutics's activity chart (see below) currently has 4 price targets and 1 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 9 days.

Most recent stock forecast was given by MATTHEW ANDREWS from on 13-Aug-2018. First documented stock forecast 19-Oct-2017.

Matthew Andrews Yasmeen Rahimi

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Aug-2018

$12

$-1788 (-99.33%)

8 years 2 months 18 days ago
(13-Aug-2018)

0/1 (0%)

$-9948 (-99.88%)

Hold

$-5.5 (-73.33%)

$30

8 years 2 months 21 days ago
(10-Aug-2018)

1/3 (33.33%)

$14.2 (165.52%)

Show more analysts

What is GEMP (Gemphire Therapeutics) average time for price targets to be met?

On average it took 9 days for the stock forecasts to be reached, with an average price target met ratio of 11.11%.

Which analyst most recently updated their price target on GEMP (Gemphire Therapeutics)?

Matthew Andrews

Which analyst has the most public recommendations on GEMP (Gemphire Therapeutics)?

Matthew Andrews has 3 price targets and 3 ratings on GEMP

Which analyst is the currently most bullish on GEMP (Gemphire Therapeutics)?

Yasmeen Rahimi with the highest potential upside of $-5.5

Which analyst is the currently most reserved on GEMP (Gemphire Therapeutics)?

Matthew Andrews with the lowest potential downside of -$1788